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Abstract
Introduction: We aimed to determine the number of repeated cholesterol (RC) tests and the ratio of unnecessary-repeated cholesterol (URC) tests 
among patients admitted to Pamukkale University Hospital (Denizli, Turkey) and provide solutions to avoid URC testing.
Materials and methods: Total cholesterol (T-cholesterol) tests (N = 86,817) between June 2014 and May 2015 were evaluated. The tests perfor-
med more than once per patient were determined as RC test (N = 28,811). RC test with an interval shorter than 4 weeks were determined as URC test 
(N = 3968) according to the shortest retest interval stated in ACC/AHA blood cholesterol guideline. RC testing included internal medicine, surgery 
and paediatric outpatients and inpatients. Reference change value (RCV) of total cholesterol was calculated.
Results: The 33.1% of the T-cholesterol tests were RC tests (N = 28,811), 13.7% of them were URC tests (N = 3968). Our RCV value was 25%. The 
percentage change between consecutive tests was less than RCV in 86.1% (N = 3418) of URC tests. URC tests were performed more frequently in 
patients with desirable total cholesterol value (P < 0.001).
Conclusion: There is a significant part of repeated T-cholesterol tests requested in our hospital. URC test requests can be evaluated by laboratories 
and the obtained data should be shared with clinicians. Laboratories can calculate RCV for the tests they performed and report this value with the 
test result. To prevent from URC tests, a warning plug-in can be added to hospital information software in accordance with guidelines to prevent 
from URC test requests.
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Introduction
The laboratory test costs, which are the remarka-
ble part of hospital expenditures, increases over 
the years (1-4). An important part of the laboratory 
tests consists of repeated tests (4-6). Repeated 
tests are used for patient monitoring, but some of 
these tests are performed unnecessarily (1,6,4,7). 
Unnecessary tests increase the laboratory work-
load and costs (1,8-10). 
Cholesterol test is one of the common performed 
tests in laboratory. Over the last two decades, the 
number of total cholesterol requests per year in-
creased more than 15-fold (4). Minimum retest in-
tervals are recommended to avoid unnecessary re-
peated cholesterol (URC) tests (11-13). According to 
“National Cholesterol Education Program Expert 
Panel on Detection, Evaluation, and Treatment of 
High Blood Cholesterol in Adults III”, lipoprotein 
profile screening should be done once every 5 
years in healthy adults above 20 years old (11). The 
American Diabetes Association (ADA) recom-
mends lipoprotein profile screening at diabetes di-
agnosis, at an initial medical evaluation and/or at 
the age of 40 and every 1-2 years (12). American 
College of Cardiology/American Heart Association 
(ACC/AHA) blood cholesterol guideline recom-
mends lipoprotein profile monitoring subsequent 
to initiation of statin therapy and followed by a 
second lipoprotein panel 4 to 12 weeks after. 
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Thereafter, monitoring should be performed eve-
ry 3 to 12 months as clinically indicated (13). 
In this study, we aimed to determine the number 
of repeated cholesterol (RC) test and the ratio of 
unnecessary repeated cholesterol (URC) tests 
among patients admitted to Pamukkale University 
Hospital (Denizli, Turkey) and to provide solutions 
in order to avoid URC testing.
Materials and methods
Study design
The results of all total cholesterol tests which were 
performed from June 2014 to May 2015 in Pamuk-
kale University Hospital Central Laboratory Bio-
chemistry Department were obtained from the 
laboratory information management system. Cho-
lesterol tests which were performed during this 
period (86,817 tests) were evaluated in the study.
Request dates, requesting services and total cho-
lesterol results were determined from the ob-
tained data. The cholesterol tests which requested 
for once in study period were excluded. The tests 
which were performed more than once per patient 
in study period were included and determined as 
RC test (N = 28,811). Cholesterol retest intervals for 
RC tests were calculated with the interval between 
consecutive tests. Any RC test which had an inter-
val shorter than 4 weeks were determined as URC 
test (N = 3968 tests) according to the shortest in-
terval stated in ACC/AHA blood cholesterol guide-
line. 
RC test rates were 84.3% (N = 24,288) in internal 
medicine outpatient, 7.3% (N = 2112) in internal 
medicine inpatient, 4.8% (N = 1385) in surgery out-
patient, 2% (N = 573) in paediatric outpatient, 1.2% 
(N = 333) in surgery inpatient and 0.4% (N = 120) in 
paediatric inpatient services (Table 1).
Methods
We used the desirable total cholesterol value cut-
off as 5.17 mmol/L in our study (11). All tests were 
run on Roche Cobas c701 chemistry analyser 
(Roche Diagnostics GmbH, Mannheim, Germany). 
Two levels of internal quality control (QC) materi-
als, total cholesterol control level 1 (mean = 2.43 
mmol/L, range: 2.17 – 2.68 mmol/L) and level 2 
(mean = 4.57 mmol/L, range: 4.11 – 5.04 mmol/L) 
were assayed during the study period. Standard 
deviation (SD) and coefficient of variation (CV) val-
ues for the levels of internal quality control materi-
als were calculated during June 2014 - May 2015 
(Table 2).
Reference change value (RCV), which used for 
evaluating the clinical significance of changes in 
consecutive test results from an individual, were 
calculated for cholesterol tests of our laboratory . 
RCV was calculated according to naturally occur-
ring variables (analytical CV and within subject CV) 
(14).
Statistical analysis
Descriptive statistics and chi-square analysis were 
done using SPSS 17.0 (SPSS Inc., Chicago, IL, USA). 
Number and percentage of the groups were calcu-
lated. RCV was calculated with formulae:
RCV = 21/2 × Z × √ (CVanalytical² + CVintraindividual²) (14).
Z is the number of standard deviations appropri-
ate to the probability (15). Z value is 2.58 for 99% 
probability (P < 0.01) (16). CVintraindividual value is 
5.95 for total cholesterol (17). CVanalytical value was 
calculated with the mean CV of our level 1 and lev-
el 2 internal quality controls. CV was calculated 
Services
Repeated Cholesterol 
Tests
% N
Surgery inpatient 1.2 333
Paediatric inpatient 0.4 120
Internal medicine inpatient 7.3 2112
Surgery outpatient 4.8 1385
Paediatric outpatient 2.0 573
Internal medicine outpatient 84.3 24,288
TOTAL 100 28,811
Table 1. Percentage of repeated cholesterol test requests 
based on services.
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from the internal quality controls data over the 
one-year period using the following equation:
CV (%) = (standard deviation × 100) / labo-
ratory mean (internal quality control). 
Results
The 33.1% of the 86,817 total cholesterol tests per-
formed during one-year period was RC test and 
13.7% of RC tests were URC test. Distribution of RC 
tests according to services was shown in table (Ta-
ble 1). 
URC test frequencies in RC tests were highest in 
surgery inpatient and lowest in internal medicine 
outpatient service (P < 0.001). In RC tests, the ratio 
of URC tests according to services was shown in 
table (Table 3). 
Our CVanalytical value was 3.25%. According to our 
CVanalytical value, we calculated the total cholester-
ol RCV value, which is specific for our laboratory. 
Our RCV value was 25%.
Months
Level 1 (normal) Level 2 (pathological)
SD CV (%) SD CV (%)
June 2.33 1.57 2.12 2.78
July 3.33 2.78 3.02 4.95
August 2.99 3.40 2.72 6.01
September 3.41 3.40 3.10 5.97
October 3.44 3.32 3.27 5.88
November 3.72 3.20 3.59 5.77
December 3.81 3.31 3.64 5.91
January 3.97 3.52 3.72 6.31
February 3.12 3.25 2.94 5.69
March 3.26 3.26 3.05 5.75
April 3.47 3.15 3.32 5.60
May 3.53 3.50 3.34 6.21
MEAN 3 .36 3 .14 3 .15 5 .57
SD – standard deviation, CV - coefficient of variation.
Table 2. Standard deviation (SD) and coefficient of variation (CV) values for the levels of internal quality control materials during June 
2014 - May 2015.
Services
Unnecessary 
Repeated 
Cholesterol 
Tests*
N (%)
Appropriate 
Repeated 
Cholesterol 
Tests*
N (%)
Surgery inpatient 228 (68.4) 105 (31.6)
Paediatric inpatient 65 (54.1) 120 (45.9)
Internal medicine 
inpatient
911 (43.1) 1201 (56.9)
Surgery outpatient 275 (19.8) 1110 (80.2)
Paediatric outpatient 107 (18.6) 466 (81.4)
Internal medicine 
outpatient
2382 (9.8) 21,906 (90.2)
*Unnecessary repeated cholesterol test is any repeated 
cholesterol test which had an interval shorter than 4 weeks.
Table 3. The ratios of “unnecessary repeated cholesterol tests” 
in repeated cholesterol tests according to services.
The percentage of the change in total cholesterol 
values between consecutive tests were less than 
RCV in 86.1% (N = 3418) of URC tests.
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URC tests were performed more frequently in pa-
tients with desirable total cholesterol value (P < 
0.001). Previous cholesterol test results were below 
desirable total cholesterol value in 62.3% of RC 
tests (N = 17,967). The percentage of the change in 
repeated total cholesterol values were less than 
RCV (N = 15,520) in 86.3% of these tests (Table 4).
Discussion
Our findings indicate that one of three total cho-
lesterol tests performed in our hospital was RC 
tests and also 13.7% of these tests were repeated 
unnecessarily. As we were not able to investigate 
the clinical features of these patients, we used the 
shortest retest interval stated at 2013 ACC/AHA 
blood cholesterol guideline. We consider that, if 
appropriate retest intervals for different clinical 
features were used, the rate of URC tests would be 
higher.
One of the ways to evaluate the significance of dif-
ference between measurements is using RCV (18). 
RCV is caused by changes which are arisen from 
analytical and biological variation between con-
secutive tests (19). The percentage change be-
tween consecutive total cholesterol tests were less 
than RCV in 86.3% of the URC tests in our study. 
This situation suggests that the change below RCV 
between consecutive URC tests is not associated 
with clinical intervention in our hospital.
Doll et al. (4) had evaluated cholesterol test re-
quests between the years 1987–2007; the propor-
tion of RC tests were 47% in years 1987–1989 and 
rose to 79% in years 2005–2007. A considerable 
part of cholesterol test requests consists of RC 
tests, as in our study. Majority of RC tests were 
from the outpatient internal medicine service in 
our study but the rate of URC tests was highest in 
inpatient services. Bridges et al. (9) had evaluated 6 
common laboratory test requests in a group of 
hospitalized patients over a 12-month period and 
7.7% were considered as unnecessary requests. It 
was stated that those unnecessary requests had 
increased the total cost and decreased the patient 
care efficiency. Oliveira et al. (3) found the rate of 
unnecessary tests 41% in intensive care unit. Miya-
kis et al. (20) found that 28.6% of tests conducted 
at the day of hospitalization are unnecessary and 
in the following days, it can increase up to 69.3%. 
We consider that, inadequate examination of pre-
vious test results in inpatient clinics of our hospital 
was the reason for this situation. 
Biochemical profile tests are performed more fre-
quently in patients with normal test results (21). In 
our study, previous test results were below the de-
sirable total cholesterol value in 62.3% of RC test re-
quests. The percentage of the change between 
consecutive tests was above RCV in majority of 
these tests. This situation supports the importance of 
minimum retest intervals suggested in guidelines.
This study had several limitations. First of all, we 
were not able to investigate the clinical features of 
the patients. Secondly, the study was conducted 
in tertiary care hospital setting, which may limit 
generalizing of our findings to other hospitals. 
And the last, evaluation was made only for total 
cholesterol test.
In conclusion, this study revealed that, an impor-
tant part of total cholesterol tests requested in Pa-
mukkale University Hospital are repeated tests. 
Unnecessary repeated test requests can be evalu-
ated by laboratories and the obtained data should 
be shared with hospital managers and clinicians. 
Laboratories can calculate RCV for the tests they 
performed and report this value with the test re-
sult. To prevent from unnecessary repeated tests, a 
warning plug-in can be added to hospital informa-
tion software in accordance with guidelines to 
prevent from unnecessary repeated test requests.
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Total 
cholesterol 
concentration 
(mmol/L)
< RCV ≥ RCV
TotalN % N %
< 5 .17 15,520 86.3 2447 13.7 17,967
≥ 5 .17 9176 84.6 1668 15.4 10,844
RCV - reference change value
Table 4. Distribution of repeated cholesterol tests according to 
reference change value and desirable total cholesterol concen-
tration.
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